For the first time, the company introduced Zhang Qiang, a national leader, as the chief scientist of Jianfeng Pharmaceutical.
Release time:
2022-07-24
News from our newspaper # In early February, Dr. Zhang Qiang, a national leader and former researcher at the Karolinska Institute in Sweden, officially joined Spike as the chief scientist of Spike Pharmaceutical. This is the first time that Jianfeng has introduced national leading talents, and it is also the first time that Wucheng District has introduced national leading talents by enterprises.
national leading talents, that is, those selected into the national "tens of millions of talents project", can focus on the national development strategic objectives, in national key innovation projects, key disciplines and key laboratories, central enterprises and state-owned commercial financial institutions, and various parks dominated by high-tech industrial development zones, To achieve breakthrough in key technologies, develop high-tech industries, and drive strategic scientists and leading talents in emerging disciplines. Dr. Zhang Qiang, who was introduced by the company this time, was born in 1981 . After completing his bachelor's and master's studies at Jilin Agricultural University and Beijing Jiaotong University, he studied for a doctor's degree in life science at the Karolinska Institute in Sweden, which ranks fifth in the world for medical majors. After graduation, he conducted postdoctoral research and served as a researcher in the institute. Dr. Zhang has technical expertise in cell culture, cell transfection, cell proliferation assay, pharmaceutical pharmacology, protein structure simulation, structure-activity relationship (SAR) , etc., and has more than ten years of small molecule anti-tumor drug research and development experience, and has rich experience in drug screening and development. After joining Jianfeng Pharmaceutical, he will use his technical expertise to be responsible for the establishment of drug screening platforms and research on drug mechanisms, cell testing, and pharmacology research.
Continuously introducing high-end talents and optimizing the peak talent structure have always been the direction of the company's talent strategy. Xiang Chongping, deputy general manager of the group company, said that the introduction of national leading talents is an important achievement of the company's human resources work. Taking this as an opportunity, the company will further strengthen the introduction of talents, continuously optimize the talent management and use mechanism, and give foreign talents the space and stage to fully display their talents, so as to attract more high-end talents to join the peak; at the same time, it will also strengthen the training of internal talents, promote their faster growth, promote the continuous optimization of the company's talent team, and provide greater impetus for the innovation and development of enterprises.
(Reporter)
More information
The company's vocational skill level independently identifies two new occupations
A few days ago, after the examination and approval of the Jinhua Municipal Bureau of Human Resources and Social Security, and reported to the Provincial Department of Human Resources and Social Security for examination and filing, Jianfeng Group's independent identification level of vocational skills was based on last year. Two new occupations (types of work) are chemical inspectors and organic synthesis workers.
2022
05-20
On May 12, Cai Xiaochun, deputy secretary of the Party group of Zhejiang Federation of industry and commerce, and his party visited Jianfeng group for investigation, visited Jinxi factory area of Jianfeng pharmaceutical factory and Jinxi internationalization project site, and had a discussion with Jiang Xiaomeng, chairman of the group company, Huang Jinlong, deputy general manager of the group company and general manager of the pharmaceutical company.
2022
05-20
On the afternoon of April 6, Jiang Xiaomeng, chairman of the group company, was invited to participate in the Jinhua News Client Financial Media Interview column "Night Talk of the Two Sessions", as a representative of the Jinhua Municipal People's Congress, to talk about suggestions for the future development of Jinhua enterprises. As the chairman of the Jinhua City Federation of Industry and Commerce, Jiang Xiaomeng has a personal experience of various problems encountered in the development of Jinhua enterprises. After careful investigation and full preparation, he put forward two proposals on strengthening the empowerment and allocation of production factors and further enhancing the market competitiveness of enterprises in our city and further promoting the compliance construction of private enterprises in our city and reducing the risk of enterprise operation. In the "two sessions night talk" interview, he put forward his own views on these two topics.
2022
04-12
Group Companies Commend 2021 Advanced
On the morning of January 26, the group company held the 2021 annual summary commendation meeting to review the work of the previous year, make arrangements for the work of 2022, sign the 2022 economic responsibility system with various professional companies and directly affiliated enterprises, and solemnly commend the 2021 advanced collectives and individuals.
2022
02-08
Group Company Convenes Workers' Representative and Trade Union Member Representative Conference
The group company held a representative meeting of staff representatives and trade union members, elected members of the eighth trade union committee and members of various special committees, and Shi Fu was elected chairman of the eighth trade union of the group trade union.
2022
02-08
The group company held an annual safety and environmental protection work conference to comprehensively summarize and review the safety and environmental protection work in 2021, make arrangements for the safety and environmental protection work in 2022, and sign the safety and environmental protection work responsibility system.
2022
02-08